Current issue
Archive
Videos
Articles in press
About the journal
Supplements
Editorial board
Reviewers
Abstracting and indexing
Subscription
Contact
Instructions for authors
Publication charge
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
2/2024
vol. 126 abstract:
Review paper
Macular abnormalities in retinitis pigmentosa. Management and treatment
Magdalena Durajczyk
1
,
Katarzyna Seredyńska
1
,
Wojciech Lubiński
1
KLINIKA OCZNA 2024, 126, 2: 59-64
Online publish date: 2024/05/22
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Aim
To review the current state of knowledge on macular in retinitis pigmentosa, current treatment methods and management. Material and methods Analysis of literature available on PubMed. Presentation of own treatment results. Results Macular lesions occur in 11.5% to 59.7% of patients with pigmentary degeneration. The most commonly observed macular abnormalities include cystoid macular edema, epiretinal membranes, vitreomacular traction syndrome, and full-thickness macular holes. In conservative treatment, topical carbonic anhydrase inhibitors and steroids are the most effective. The best surgical treatment outcomes have been obtained for macular holes. Conservative and surgical treatment outcomes vary and depend on the stage of retinitis pigmentosa. Conclusions Macular abnormalities are often observed in patients with retinitis pigmentosa. arbonic anhydrase blockers and steroids can be effective in treating cystoid macular edema. Surgical treatment can improve macular morphology but improvement in visual function is limited due to long-term retinal dysfunction and progression of the underlying disease. keywords:
retinitis pigmentosa, macular abnormalities, present knowledge |
|